Genetic markers in diabetes mellitus: the need and promise for specific drug therapies in defined subtypes of diabetes patients
Healthy genome sequenced to predict risk of disease and response to treatments
US FDA approves first fully automated blood test for Chagas disease
Novel biomarkers predict resistance to endocrine therapy in breast cancer
Cofilin expression levels serve as an indicator for lung cancer progression risk and response to treatment
Multiplex PCR testing for respiratory viruses receives boost
Simple gene tests are best for subtyping breast cancer
CD44 as a therapeutic target for glioblastoma
STAT3 phosphorylation: marker of aggressive glioblastomas
MGMT promoter methylation as a predictive biomarker of radiation response
Biomarkers for brain disorders
Blood biomarkers to identify ischemic stroke etiologies
Natriuretic peptides in heart failure
Biomarkers for drug-induced liver injury
Xenotropic murine leukemia virus-related virus: current research, disease associations and therapeutic opportunities
HIV vaccine study approved
Recruitment halted in the EMPHASIS-HF trial as primary end point reached earlier than expected
Antiobesity drug application accepted by US FDA
Specially trained dogs detect prostate cancer-derived compounds in urine
EMA and US FDA approve Prolia® for the treatment of postmenopausal osteoporosis
Red heart polypill to be tested in new international trial
Role of sotalol in rhythm control of atrial fibrillation
An overview of satavaptan: a selective V2 receptor antagonist
The new Invisio® DUR-D ‘chip-on-the-tip’ digital flexible ureterorenoscopes: evaluation of changes in physical properties over time
Rupatadine 10 mg in adolescent and adult symptom relief of perennial allergic rhinitis
Acknowledgements